share_log

12 Health Care Stocks Moving In Monday's Pre-Market Session

Benzinga ·  Apr 10, 2023 21:10

Gainers

  • PLx Pharma (NASDAQ:PLXP) stock increased by 181.6% to $0.3 during Monday's pre-market session. The company's market cap stands at $8.6 million.
  • OncoSec Medical (NASDAQ:ONCS) shares moved upwards by 70.53% to $1.91. The company's market cap stands at $5.6 million.
  • GlucoTrack (NASDAQ:GCTK) shares moved upwards by 31.93% to $1.57. The company's market cap stands at $24.3 million.
  • Healthcare Triangle (NASDAQ:HCTI) shares increased by 29.4% to $0.41. The company's market cap stands at $17.3 million.
  • Heart Test Laboratories (NASDAQ:HSCS) shares rose 20.44% to $1.09. The company's market cap stands at $10.6 million.
  • GreenLight Biosciences (NASDAQ:GRNA) shares moved upwards by 14.21% to $0.49. The company's market cap stands at $73.7 million.

Losers

  • Pear Therapeutics (NASDAQ:PEAR) shares fell 12.4% to $0.2 during Monday's pre-market session. The market value of their outstanding shares is at $28.1 million.
  • Titan Pharma (NASDAQ:TTNP) stock decreased by 10.01% to $0.72. The market value of their outstanding shares is at $10.8 million.
  • Perspective Therapeutics (AMEX:CATX) shares decreased by 8.61% to $0.58. The market value of their outstanding shares is at $163.0 million.
  • Vallon Pharmaceuticals (NASDAQ:VLON) shares fell 8.17% to $0.36. The company's market cap stands at $4.8 million.
  • Aridis Pharmaceuticals (NASDAQ:ARDS) stock fell 7.57% to $0.24. The company's market cap stands at $8.8 million.
  • Addex Therapeutics (NASDAQ:ADXN) shares fell 6.85% to $0.68. The company's market cap stands at $10.0 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment